Clinical trials
Dementia trials in France with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
43 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 2 |
| 2009 | 2 |
| 2010 | 3 |
| 2012 | 2 |
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 3 |
| 2016 | 2 |
| 2017 | 4 |
| 2019 | 3 |
| 2020 | 4 |
| 2021 | 2 |
| 2022 | 5 |
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 3 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 27 |
| Recruiting | 6 |
| Unknown status | 5 |
| Not yet recruiting | 3 |
| Active, not recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Assistance Publique - Hôpitaux de Paris | 4 |
| Centre Hospitalier Universitaire, Amiens | 4 |
| University Hospital, Bordeaux | 4 |
| University Hospital, Toulouse | 4 |
| Centre Hospitalier Universitaire de Nice | 3 |
| Hospices Civils de Lyon | 3 |
| Institut National de la Santé Et de la Recherche Médicale, France | 2 |
| LNA SANTE | 2 |
| CHU de Reims | 1 |
| Central Hospital Saint Quentin | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Dementia | 43 |
| Alzheimer Disease | 16 |
| Cognitive Dysfunction | 13 |
| Stroke | 5 |
| Lethargy | 4 |
| Cerebral Small Vessel Diseases | 3 |
| Disease | 3 |
| Dementia, Vascular | 2 |
| Heart Diseases | 2 |
| Kidney Diseases | 2 |
Trials
Showing 1 to 25 of 43. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.